Kidney Insufficiency
10
0
0
3
Key Insights
Highlights
Success Rate
60% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 60/100
20.0%
2 terminated out of 10 trials
60.0%
-26.5% vs benchmark
10%
1 trials in Phase 3/4
67%
2 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (10)
Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease
The WavelinQ™ Arterio-Venous Endovascular Fistula: A Global, Post-Market Investigation
Vocorder Device Validation in Clinical Settings - Continuous Monitoring of Individuals (Vocorder Clinical Validation-VCV)
Effectiveness of Drainage by PCN vs. JJ in Patients With Symptoms of Obstructive Kidney Disease Caused by Urolithiasis
Rituximab Treatment to Block HLA Antibodies in Renal Transplant Recipients
Rituximab Therapy for Patients on Kidney Transplant Waiting List With Positive Donor Specific Crossmatch to Living Donor
Metformin Versus Vildagliptin in Reducing Risk of Metabolic Syndrome Complications Progression
Plant Versus Animal Dietary Protein and the Effect on Proteinuria
Determination In-vivo KUF for Diacap Pro Hemodialyser
Long-Term Therapy Outcomes When Treating Chronic Kidney Disease (CKD) Patients With Paricalcitol in German and Austrian Clinical Practice